Concert Pharmaceuticals, Inc

CNCE NASDAQ
CNCE
Concert Pharmaceuticals, Inc NASDAQ
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

CNCE financial statements: Cash flow

An in-depth look to Concert Pharmaceuticals, Inc operating, investing, and financing activities

CNCE free cash flow for Q2 21 is 10.86M. For 2020, CNCE free cash flow was -68.98M and operating cash flow was -68.77M.

TTM
Cash from operating activities
Funds from operations
Changes in working capital
Cash from investing activities
Purchase/sale of business, net
Purchase/sale of investments, net
Capital expenditures
Other investing cash flow items, total
Cash from financing activities
Issuance/retirement of stock, net
Issuance/retirement of debt, net
Total cash dividends paid
Other financing cash flow items, total
Free cash flow